Impact of angiographic peri-stent contrast staining (PSS) on late adverse events after sirolimus-eluting stent implantation: an observation from the multicenter j-Cypher registry PSS substudy

[1]  G. Nakazawa,et al.  Angiographic findings of everolimus-eluting as compared to sirolimus-eluting stents: angiographic sub-study from the Randomized Evaluation of Sirolimus-eluting versus Everolimus-eluting stent Trial (RESET) , 2013, Cardiovascular Intervention and Therapeutics.

[2]  K. Kadota,et al.  Optical Coherence Tomography Findings in Lesions After Sirolimus-Eluting Stent Implantation With Peri-Stent Contrast Staining , 2012, Circulation. Cardiovascular interventions.

[3]  H. Fujita,et al.  Antiplatelet therapy and long-term clinical outcome after sirolimus-eluting stent implantation: 5-year outcome of the j-Cypher registry , 2012, Cardiovascular Intervention and Therapeutics.

[4]  MasakiyoNobuyoshi,et al.  Very Late Stent Thrombosis and Late Target Lesion Revascularization After Sirolimus-Eluting Stent Implantation , 2012 .

[5]  Y. Hayashi,et al.  Very late stent thrombosis and late target lesion revascularization after sirolimus-eluting stent implantation: five-year outcome of the j-Cypher Registry. , 2012, Circulation.

[6]  K. Sakakura,et al.  Occurrence of late acquired peri-stent contrast staining: comparison between sirolimus-eluting stents and everolimus-eluting stents. , 2012, International heart journal.

[7]  Takeshi Kimura,et al.  Incidence, Risk Factors, and Clinical Sequelae of Angiographic Peri-Stent Contrast Staining After Sirolimus-Eluting Stent Implantation , 2011, Circulation.

[8]  Takeshi Kimura,et al.  Contrast staining outside the sirolimus-eluting stent leading to coronary aneurysm formation: a case of very late stent thrombosis associated with hypersensitivity reaction. , 2011, Circulation. Cardiovascular interventions.

[9]  Yoshihisa Nakagawa,et al.  Very Long-Term (15 to 20 Years) Clinical and Angiographic Outcome After Coronary Bare Metal Stent Implantation , 2010, Circulation. Cardiovascular interventions.

[10]  T. Kume,et al.  Comparisons of Baseline Demographics, Clinical Presentation, and Long-Term Outcome Among Patients With Early, Late, and Very Late Stent Thrombosis of Sirolimus-Eluting Stents: Observations From the Registry of Stent Thrombosis for Review and Reevaluation (RESTART) , 2010, Circulation.

[11]  Johan Lindbäck,et al.  Long-term safety and efficacy of drug-eluting versus bare-metal stents in Sweden. , 2009, The New England journal of medicine.

[12]  C. Macaya,et al.  Coronary aneurysms after drug-eluting stent implantation: clinical, angiographic, and intravascular ultrasound findings. , 2009, Journal of the American College of Cardiology.

[13]  Y. Hayashi,et al.  Antiplatelet Therapy and Stent Thrombosis After Sirolimus-Eluting Stent Implantation , 2009, Circulation.

[14]  S. John,et al.  Very late stent thrombosis associated with multiple stent fractures and peri-stent aneurysm formation after sirolimus-eluting stent implantation. , 2008, Circulation journal : official journal of the Japanese Circulation Society.

[15]  Josepa Mauri,et al.  Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio ESpañol sobre TROmbosis de stents FArmacoactivos). , 2008, Journal of the American College of Cardiology.

[16]  John Bresnahan,et al.  Outcomes of Stent Thrombosis and Restenosis During Extended Follow-Up of Patients Treated With Bare-Metal Coronary Stents , 2007, Circulation.

[17]  R. Perry,et al.  Late stent thrombosis associated with coronary aneurysm formation after sirolimus-eluting stent implantation. , 2007, The Journal of invasive cardiology.

[18]  Ralph D'Agostino,et al.  Stent thrombosis in randomized clinical trials of drug-eluting stents. , 2007, The New England journal of medicine.

[19]  Marco Valgimigli,et al.  Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents. , 2007, The New England journal of medicine.

[20]  Neville Kukreja,et al.  Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study , 2007, The Lancet.

[21]  Michael Joner,et al.  Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. , 2006, Journal of the American College of Cardiology.

[22]  Giuseppe Musumeci,et al.  Localized Hypersensitivity and Late Coronary Thrombosis Secondary to a Sirolimus-Eluting Stent: Should We Be Cautious? , 2004, Circulation.

[23]  S. Ellis.  Interventions in acute myocardial infarction. , 1988, Circulation.